bioRxivPharmacology & Toxicology
Towards the Target: Tilorone, Quinacrine and Pyronaridine Bind to Ebola Virus Glycoprotein
Abstract
Pyronaridine, tilorone and quinacrine were recently identified by a machine learning model and demonstrated in vitro and in vivo activity against Ebola virus (EBOV) and represent viable candidates for drug repurposing. These drugs were docked into the crystal structure of the ebola glycoprotein and then experimentally validated in vitro to generate Kd values for tilorone (0.73 μM) pyronaridine (7.34 μM), and quinacrine (7.55 μM). These are more potent than the previously reported toremifene (16 μM).View Full Text
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms
A. C. Puhl, E. J. Fritch, … S. Ekins·bioRxiv·Dec 1, 2020
- Pyronaridine Tetraphosphate Efficacy Against Ebola Virus Infection in Guinea Pig
T. R. Lane, C. Massey, … S. Ekins·bioRxiv·Mar 20, 2020
- Tilorone: A Broad-Spectrum Antiviral For Emerging Viruses
- Repurposing Pyramax for the Treatment of Ebola Virus Disease: Additivity of the Lysosomotropic Pyronaridine and Non-Lysosomotropic Artesunate
T. R. Lane, J. Dyall, … S. Ekins·bioRxiv·Apr 25, 2020
- In-silico Screening of Origanum vulgare Phytocompounds as Potential Drug Agents Against Vp35 Protein of the Ebola Virus
Malaika Saeed, Aqeela Ashraf, … Rashid Saif·bioRxiv·Mar 25, 2023
- The Prophylactic and Therapeutic Efficacy of the Broadly Active Antiviral Ribonucleoside N4-Hydroxycytidine (EIDD-1931) in a Mouse Model of Lethal Ebola Virus Infection
G. R. Bluemling, S. Mao, … G. R. Painter·bioRxiv·Oct 18, 2022